Journal articles on the topic 'Inc National Cargo Bureau'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Inc National Cargo Bureau.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Lebwohl, M., A. Deodhar, S. Schwartzman, C. Salvarani, M. Feely, D. Zhu, P. Rahman, et al. "AB1105 LONG-TERM SAFETY OF IXEKIZUMAB TREATMENT IN ADULT PATIENTS WITH PSORIASIS, PSORIATIC ARTHRITIS, OR AXIAL SPONDYLOARTHRITIS: A POST-HOC ANALYSIS OF END-OF-STUDY PROGRAM DATA RELATING TO MAJOR ADVERSE CARDIOVASCULAR EVENTS." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1780–81. http://dx.doi.org/10.1136/annrheumdis-2023-eular.3412.
Full textMatsui, T., N. Sugiyama, S. Toyoizumi, F. Matsuyama, T. Murata, Y. Urata, K. Kawahata, and S. Tohma. "POS0286 INCIDENCE OF MALIGNANCIES IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM A LARGE JAPANESE NATIONAL REGISTRY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 368–69. http://dx.doi.org/10.1136/annrheumdis-2021-eular.365.
Full textBishop, Ryan T., Tao Li, Raghunandan R. Alugubelli, Oliver Hampton, Ariosto Siqueira Silva, Steven Grant, Kenneth H. Shain, and Conor C. Lynch. "Acid Ceramidase (ASAH1) Mediates Intrinsic and Intercellular Transfer of Proteasome Inhibitor Resistance in Multiple Myeloma." Blood 138, Supplement 1 (November 5, 2021): 1206. http://dx.doi.org/10.1182/blood-2021-152686.
Full textKhuat, Lam T., Catherine T. Le, Chien-Chun Pai, Robin Shields-Cutler, Shernan Holtan, Armin Rashidi, Sarah Parker, et al. "Obesity-Induced Microbiome Alterations Result in Severe Gastrointestinal Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation." Blood 134, Supplement_1 (November 13, 2019): 1922. http://dx.doi.org/10.1182/blood-2019-127743.
Full textYijun, Liao, Li Ping, and Huang Wenjing. "Research on the Impact of GNI on Express Delivery Volume in China." Journal of Economics and Public Finance 6, no. 3 (August 12, 2020): p110. http://dx.doi.org/10.22158/jepf.v6n3p110.
Full textNakazaki, Kumi, Toshiaki Takezaki, Yosuke Masamoto, Yasushi Miyazaki, Kinuko Mitani, and Mineo Kurokawa. "A Nationwide Survey of Lower Risk Myelodysplastic Syndromes in Japan." Blood 138, Supplement 1 (November 5, 2021): 4662. http://dx.doi.org/10.1182/blood-2021-146093.
Full textDiugwu, Ikechukwu A., Obioma R. Nwaogbe, Victor Omoke, Solomon T. Johnson, and Ashem E. Egila. "Assessment of operational performance of public sector funded infrastructure in Nigeria: the airports perspective." Independent Journal of Management & Production 10, no. 1 (February 1, 2019): 133. http://dx.doi.org/10.14807/ijmp.v10i1.828.
Full textOjutalayo, John Folayan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu, Akujuobi Aghaegbulam Bonaventure Chidiebere, and Theophilus Chinonyerem Nwokedi. "Poverty, Youth Unemployment, Maritime Piracy, and Sea Robbery in Nigeria between 1995 and 2013: A Relationship Assessment." Maritime Technology and Research 5, no. 4 (July 13, 2023): 265349. http://dx.doi.org/10.33175/mtr.2023.265349.
Full textRubnitz, Jeffrey E., Thomas B. Alexander, Theodore W. Laetsch, Seong Lin Khaw, Vinod A. Pullarkat, Joseph T. Opferman, Kathryn G. Roberts, et al. "Venetoclax and Navitoclax in Pediatric Patients with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma." Blood 136, Supplement 1 (November 5, 2020): 12–13. http://dx.doi.org/10.1182/blood-2020-134582.
Full textCasulo, Carla, Michelle Byrtek, Keith L. Dawson, Xiaolei Zhou, Christopher R. Flowers, Charles M. Farber, John D. Hainsworth, James R. Cerhan, Brian K. Link, and Jonathan W. Friedberg. "Disease Characteristics, Treatment Patterns, and Outcomes of Follicular Lymphoma in Patients 40 Years of Age and Younger: An Analysis from the National LymphoCare Study." Blood 124, no. 21 (December 6, 2014): 3044. http://dx.doi.org/10.1182/blood.v124.21.3044.3044.
Full textLee, Seung Tae, Antonio Pinto, Habte Yimer, Don Stevens, Wanda Knopinska Posluszny, Merrill Kingman Shum, Sudhir Manda, et al. "A Phase 2/3, Multicenter Randomized Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) with or without Selinexor in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR DLBCL)." Blood 138, Supplement 1 (November 5, 2021): 1420. http://dx.doi.org/10.1182/blood-2021-150025.
Full textJourneycake, Janna M., Cedric Hermans, Jonathan M. Ducore, Miguel A. Escobar, Guy Young, Michael Wang, Doris Quon, et al. "Single 225μg/Kg Dose Treatment with Eptacog Beta (Factor VIIa, Recombinant) Results in Rapid Hemostasis in Joint Bleeds for Persons with Hemophilia Α or Β with Inhibitors: A PERSEPT1 Subset Analysis." Blood 136, Supplement 1 (November 5, 2020): 2–3. http://dx.doi.org/10.1182/blood-2020-136443.
Full textConnelly, K., R. Kandane-Rathnayake, V. Golder, W. Louthrenoo, Y. H. Chen, J. Cho, A. Lateef, et al. "POS1481 INFORMING TRIAL MEASUREMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS: FREQUENCY OF DOMAIN-SPECIFIC DISEASE ACTIVITY IN A MULTI-NATIONAL OBSERVATIONAL COHORT." Annals of the Rheumatic Diseases 82, Suppl 1 (May 30, 2023): 1095.2–1096. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2885.
Full textSavage, Kerry J., Steven M. Horwitz, Ranjana H. Advani, Jacob H. Christensen, Eva Domingo-Domenech, Giuseppe Rossi, Franck Morschhauser, et al. "An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant." Blood 134, Supplement_1 (November 13, 2019): 464. http://dx.doi.org/10.1182/blood-2019-122781.
Full textZinzani, Pier Luigi, Felipe Samaniego, Wojciech Jurczak, Nilanjan Ghosh, Enrico Derenzini, James A. Reeves, Wanda Knopinska-Posluszny, et al. "Umbralisib, the Once Daily Dual Inhibitor of PI3Kδ and Casein Kinase-1ε Demonstrates Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: Results from the Phase 2 Global Unity-NHL Trial." Blood 136, Supplement 1 (November 5, 2020): 34–35. http://dx.doi.org/10.1182/blood-2020-134851.
Full textPipe, Steven W., Michael Recht, Nigel S. Key, Frank W. G. Leebeek, Giancarlo Castaman, Susan U. Lattimore, Paul Van Der Valk, et al. "First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies." Blood 136, Supplement_2 (November 19, 2020): LBA—6—LBA—6. http://dx.doi.org/10.1182/blood-2020-143560.
Full textKwak, Larry W., Juan Manuel Sancho, Seok-Goo Cho, Hideyuki Nakazawa, Junji Suzumiya, Gayane Tumyan, Jin Seok Kim, et al. "Long-Term Efficacy and Safety (27 months) of the Biosimilar CT-P10 in Patients with Low Tumor Burden Follicular Lymphoma." Blood 136, Supplement 1 (November 5, 2020): 27–28. http://dx.doi.org/10.1182/blood-2020-135999.
Full textEscobar, Miguel A., Doris Quon, Cindy A. Leissinger, James V. Luck, Ahmad Al-Sabbagh, Daniel Bonzo, Ian S. Mitchell, W. Allan Alexander, and Cedric Hermans. "PERSEPT3: A Phase 3 Clinical Trial to Evaluate the Hemostatic Efficacy of Eptacog Beta (Recombinant Human FVIIa) in Perioperative Care in Subjects with Hemophilia Α or B with Inhibitors." Blood 136, Supplement 1 (November 5, 2020): 34–36. http://dx.doi.org/10.1182/blood-2020-136448.
Full textMatsuda, Kensuke, Taisuke Jo, Masashi Miyauchi, Kazuhiro Toyama, Kumi Nakazaki, Hideo Yasunaga, and Mineo Kurokawa. "Primary Prophylaxis with Pegfilgrastim in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Nation-Wide, Propensity Score Based Analysis." Blood 134, Supplement_1 (November 13, 2019): 1605. http://dx.doi.org/10.1182/blood-2019-123611.
Full textLee, Hun Ju, Michael Choi, Tanya Siddiqi, Jacqueline Barrientos, William G. Wierda, Iris Isufi, Joseph Tuscano, et al. "Phase 1b/2 Study of Cirmtuzumab and Ibrutinib in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL)." Blood 138, Supplement 1 (November 5, 2021): 3534. http://dx.doi.org/10.1182/blood-2021-148779.
Full textMcGraw, Kathy L., Chia-Ho Cheng, Y. Ann Chen, Hsin-An Hou, Guilio Genovese, Thomas Cluzeau, Andrea Pellagatti, et al. "SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition." Blood 132, Supplement 1 (November 29, 2018): 107. http://dx.doi.org/10.1182/blood-2018-99-118747.
Full textWolach, Ofir, Itai Levi, Jonathan Canaani, Tamar Tadmor, Sigal Tavor, Ilana Hellmann, Tsila Zuckerman, et al. "First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study." Blood 136, Supplement 1 (November 5, 2020): 27–28. http://dx.doi.org/10.1182/blood-2020-139923.
Full textKernder, A., H. Morf, P. Klemm, D. Vossen, M. Meyer, I. Haase, J. Mucke, et al. "POS1458-HPR DIGITAL RHEUMATOLOGY IN THE ERA OF COVID-19: RESULTS OF A NATIONAL PATIENT AND PHYSICIAN SURVEY." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 1013–14. http://dx.doi.org/10.1136/annrheumdis-2021-eular.1328.
Full textGhia, Paolo, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Bryone J. Kuss, Stephen Opat, Ian W. Flinn, et al. "First-Line Treatment with Ibrutinib (Ibr) Plus Venetoclax (Ven) for Chronic Lymphocytic Leukemia (CLL): 2-Year Post-Randomization Disease-Free Survival (DFS) Results from the Minimal Residual Disease (MRD) Cohort of the Phase 2 Captivate Study." Blood 138, Supplement 1 (November 5, 2021): 68. http://dx.doi.org/10.1182/blood-2021-144544.
Full textGribben, John G., Wojciech Jurczak, Ryan W. Jacobs, Sebastian Grosicki, Krzysztof Giannopoulos, Tomasz Wrobel, Syed F. Zafar, et al. "Umbralisib Plus Ublituximab (U2) Is Superior to Obinutuzumab Plus Chlorambucil (O+Chl) in Patients with Treatment Naïve (TN) and Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): Results from the Phase 3 Unity-CLL Study." Blood 136, Supplement 1 (November 5, 2020): 37–39. http://dx.doi.org/10.1182/blood-2020-134783.
Full textSchiller, Gary J., Laura Finn, Gail J. Roboz, Johnnie J. Orozco, Tiffany Lin, Mary M. Chen, and Mohamed M. Hegazi. "Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML." Blood 138, Supplement 1 (November 5, 2021): 3412. http://dx.doi.org/10.1182/blood-2021-146018.
Full textCostello, Caitlin L., Tara K. Gregory, Syed Abbas Ali, Jesus G. Berdeja, Krina K. Patel, Nina D. Shah, Eric Ostertag, et al. "Phase 2 Study of the Response and Safety of P-Bcma-101 CAR-T Cells in Patients with Relapsed/Refractory (r/r) Multiple Myeloma (MM) (PRIME)." Blood 134, Supplement_1 (November 13, 2019): 3184. http://dx.doi.org/10.1182/blood-2019-129562.
Full textRollison, Dana E., Kenneth H. Shain, Ji-Hyun Lee, Shalaka S. Hampras, William Fulp, Kate Fisher, Najla H. Al Ali, et al. "Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients." Blood 124, no. 21 (December 6, 2014): 1912. http://dx.doi.org/10.1182/blood.v124.21.1912.1912.
Full textContributors. "ACKNOWLEDGMENTS." Acta Medica Philippina 54, no. 6 (December 26, 2020). http://dx.doi.org/10.47895/amp.v54i6.2626.
Full textKANIA, MICHAL, BEATA KON, KONRAD M. KAMINSKI, JERZY HOHENDORFF, TOMASZ KLUPA, PRZEMYSLAW W. WITEK, and MACIEJ MALECKI. "1841-PUB: Diabetes as a Risk Factor of Death in Hospitalized COVID-19 Patients—An Analysis of a National Hospitalization Database from Poland, 2020." Diabetes 72, Supplement_1 (June 23, 2023). http://dx.doi.org/10.2337/db23-1841-pub.
Full textLEELARATHNA, LALANTHA, CHRIS J. SUTTON, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, et al. "951-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Subgroup Analysis from the FLASH-UK Study." Diabetes 72, Supplement_1 (June 20, 2023). http://dx.doi.org/10.2337/db23-951-p.
Full textFORLENZA, GREGORY P., SARAH A. MACLEISH, DOROTHY I. SHULMAN, BENJAMIN U. NWOSU, SIHAM ACCACHA, SATISH K. GARG, ANDERS L. CARLSON, et al. "1901-LB: Safety and Glycemic Outcomes Using the MiniMed 780G System with a Disposable All-in-One Sensor with Transmitter." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1901-lb.
Full textMAGLIANO, DIANNA J., LEI CHEN, JEDIDIAH I. MORTON, AGUS SALIM, BENDIX CARSTENSEN, EDWARD W. GREGG, MEDA E. PAVKOV, et al. "1380-P: A Multicountry Analysis of Trends in Incidence of Young-Onset Type 2 Diabetes." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1380-p.
Full textCHEPP, VALERIE, STEVEN P. MASIANO, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE, and ANITA D. MISRA-HEBERT. "1125-P: Provider Experience Caring for Elderly Patients with Uncontrolled Type 2 Diabetes and Hospitalization." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1125-p.
Full textOjutalayo, John Folamyan, Ndikom Obed Boniface, Nnadi Kenneth Ugwu, and Theophilus Chinonyerem Nwokedi. "Study on the Effects of Maritime Piracy and Sea Robbery on Economic Growth in Nigeria." International Journal of Social Science and Research 1, no. 1 (September 6, 2023). http://dx.doi.org/10.58531/ijssr/1/1/2.
Full textVIGERSKY, ROBERT A., BRUCE W. BODE, RONALD L. BRAZG, BRUCE A. BUCKINGHAM, ANDERS L. CARLSON, KEVIN B. KAISERMAN, MARK KIPNES, et al. "100-LB: Glycemic Control Using Recommended Settings in Youth and Adults with Type 1 Diabetes (T1D) —Minimed 780G System with the Calibration-Free Guardian 4 Sensor Results." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-100-lb.
Full textBARNARD, KATHARINE, VICKY P. TAXIARCHI, MARK EVANS, SANKALPA NEUPANE, GERRY RAYMAN, SARAH LUMLEY, IAIN C. CRANSTON, et al. "633-P: Intermittently Scanned Continuous Glucose Monitoring (isCGM) for T1DM—Psychosocial Outcomes from the FLASH-UK Study." Diabetes 72, Supplement_1 (June 20, 2023). http://dx.doi.org/10.2337/db23-633-p.
Full textMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI, et al. "1895-LB: Fasting C-Peptide and Type 1 Diabetes Polygenic Score Predict Diabetic Ketoacidosis in People with Type 2 Diabetes in DECLARE-TIMI 58." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1895-lb.
Full textMI KANG, YU, GIORGIO E. M. MELLONI, AVIVIT CAHN, ITAMAR RAZ, FILIPE MOURA, DEEPAK L. BHATT, SILVIO E. INZUCCHI, et al. "1896-LB: Clinical Features and C-Peptide Levels Associated with Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Dapagliflozin vs. Placebo—Insights from DECLARE-TIMI 58." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1896-lb.
Full textWEINSTOCK, RUTH S., ZACHARY THOMPSON, RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER, et al. "263-OR: Older Adults Benefit from Virtual Support for CGM Use but Require Longer Visits." Diabetes 72, Supplement_1 (June 20, 2023). http://dx.doi.org/10.2337/db23-263-or.
Full textMASIANO, STEVEN P., LARISA G. TERESHCHENKO, VALERIE CHEPP, ALEX MILINOVICH, JACQUELINE FOX, KEVIN M. PANTALONE, and ANITA D. MISRA-HEBERT. "1111-P: Predictors of Type 2 Diabetes (T2D) Medication Change and Improved A1C among Older Adults Post-hospitalization." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-1111-p.
Full textMILLER, KELLEE, HUYEN NGUYEN, JENNIFER L. SHERR, YOGISH C. KUDVA, ANDERS L. CARLSON, NAOMI CHAYTOR, DANIEL DESALVO, et al. "265-OR: Understanding Patterns of GLP-1/GLP-1 RA Use among Individuals with Type 1 Diabetes—A T1D Exchange (T1DX) Online Registry Analysis." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-265-or.
Full textBODE, BRUCE W., TIMOTHY S. BAILEY, KRISTIN N. CASTORINO, MARK P. CHRISTIANSEN, SATISH K. GARG, KEVIN B. KAISERMAN, DAVID R. LILJENQUIST, et al. "672-P: Performance of a New Disposable Zero-Calibration Continuous Glucose Monitoring (CGM) Sensor." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-672-p.
Full textFAULDS, EILEEN R., YASAMAN BADAKHSHI, ANDREW BOUTSICARIS, MATTHEW C. EXLINE, JOI HESTER, LAUREEN G. JONES, MOLLY MCNETT, et al. "230-OR: Hybrid Continuous Glucose Monitoring Protocols in the Intensive Care Unit—Multicenter Experience." Diabetes 72, Supplement_1 (June 20, 2023). http://dx.doi.org/10.2337/db23-230-or.
Full textEBERT, THOMAS, NOSHEEN SATTAR, MARNI GREIG, CLAUDIA LAMINA, MARC FROISSART, KAI-UWE ECKARDT, JÜRGEN FLOEGE, et al. "808-P: Association between Analogue Compared with Human Insulin and the Outcomes of Mortality, Hospitalization, MACE, and Hypoglycemia in Hemodialysis Patients with Type 2 Diabetes: The ARO Research Initiative." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-808-p.
Full textDUBSKY, MICHAL, ROBERT ROLAND, NATÁLIA MARHEFKOVÁ, PETER WOHLFAHRT, PETER NOVODVORSKY, VLADIMIR KARMAZIN, MARTIN HALUZIK, and MICHAL PAZDERNIK. "185-OR: The Role of Optical Coherent Tomography in the Estimation of Cardiovascular Risk in Asymptomatic Patients with Type 1 Diabetes." Diabetes 73, Supplement_1 (June 14, 2024). http://dx.doi.org/10.2337/db24-185-or.
Full textDESHMUKH, HARSHAL, BEATRICE PIERI, EMMA G. WILMOT, PRATIK CHOUDHARY, NAJEEB SHAH, VASILEIOS TSATLIDIS, ALISTAIR N. LUMB, ROBERT E. RYDER, CHRISTOPHER WALTON, and THOZHUKAT SATHYAPALAN. "90-OR: FreeStyle Libre (FSL) Time in Range (TIR) and Time Below Range (TBR) : Impact on HbA1c, Diabetes-Related Distress (DRD) , and Resource Utilisation in the Association of British Clinical Diabetologists (ABCD) National Audit." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-90-or.
Full textFORLENZA, GREGORY P., BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, SUE A. BROWN, RUTH S. WEINSTOCK, DAVID W. HANSEN, et al. "766-P: Glycemic Outcomes with the Omnipod 5 Automated Insulin Delivery (AID) System Stratified by Baseline Hypoglycemia Risk among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-766-p.
Full textSCHOELWER, MELISSA, BRUCE W. BODE, ANDERS L. CARLSON, AMY B. CRIEGO, GREGORY P. FORLENZA, RUTH S. WEINSTOCK, DAVID W. HANSEN, et al. "765-P: Glycemic Outcomes across Total Daily Insulin Doses with the Omnipod 5 Automated Insulin Delivery System (AID) among People with Type 1 Diabetes (T1D) Ages 2 to 70 Years." Diabetes 71, Supplement_1 (June 1, 2022). http://dx.doi.org/10.2337/db22-765-p.
Full textHOOD, KOREY K., RICHARD M. BERGENSTAL, TERRA L. CUSHMAN, ROBIN L. GAL, CRAIG KOLLMAN, DAVIDA F. KRUGER, MARY L. JOHNSON, et al. "1031-P: Virtual Clinic Support—Patient-Reported Outcome Benefits." Diabetes 72, Supplement_1 (June 20, 2023). http://dx.doi.org/10.2337/db23-1031-p.
Full text